- Home
- Publications
- Publication Search
- Publication Details
Title
Potential role of brivaracetam in pediatric epilepsy
Authors
Keywords
-
Journal
ACTA NEUROLOGICA SCANDINAVICA
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-09-24
DOI
10.1111/ane.13347
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety and tolerability of adjunctive brivaracetam in epilepsy: In-depth pooled analysis
- (2020) Christian Brandt et al. EPILEPSY & BEHAVIOR
- Brivaracetam efficacy and tolerability in clinical practice: A UK-based retrospective multicenter service evaluation
- (2020) J. Adewusi et al. EPILEPSY & BEHAVIOR
- Clinical experience with brivaracetam in a series of 46 children
- (2020) Núria Visa-Reñé et al. EPILEPSY & BEHAVIOR
- A review of the drug−drug interactions of the antiepileptic drug brivaracetam
- (2020) Brian D. Moseley et al. EPILEPSY RESEARCH
- Safety and Tolerability of Adjunctive Brivaracetam in Pediatric Patients
- (2019) Edwin Liu et al. PEDIATRIC DRUGS
- Safety and tolerability of adjunctive brivaracetam in children with focal seizures: Interim analysis of pooled data from two open-label trials
- (2019) Anup D. Patel et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- Safety and Efficacy of Brivaracetam in Pediatric Refractory Epilepsy: A Single-Center Clinical Experience
- (2019) Sara McGuire et al. JOURNAL OF CHILD NEUROLOGY
- Treatment with brivaracetam in children – The experience of a pediatric epilepsy center
- (2019) Andreea Nissenkorn et al. EPILEPSY & BEHAVIOR
- Use of brivaracetam in genetic generalized epilepsies and for acute, intravenous treatment of absence status epilepticus
- (2018) Adam Strzelczyk et al. EPILEPSIA
- Long-term retention rates of antiepileptic drugs used in acute seizures
- (2018) Manuel Toledo et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Efficacy, Retention, and Tolerability of Brivaracetam in Patients With Epileptic Encephalopathies: A Multicenter Cohort Study From Germany
- (2018) Laurent M. Willems et al. Frontiers in Neurology
- Postmarketing experience with brivaracetam in the treatment of focal epilepsy in children and adolescents
- (2018) Susanne Schubert-Bast et al. EPILEPSY & BEHAVIOR
- Postmarketing experience with brivaracetam in the treatment of epilepsies: A multicenter cohort study from Germany
- (2017) Isabel Steinig et al. EPILEPSIA
- Brivaracetam population pharmacokinetics in children with epilepsy aged 1 month to 16 years
- (2017) Rik Schoemaker et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- New developments in the management of partial-onset epilepsy: role of brivaracetam
- (2017) Giangennaro Coppola et al. Drug Design Development and Therapy
- Stereochemistry of the Brivaracetam Diastereoisomers
- (2016) Shi Qiu et al. CHIRALITY
- Synaptic Vesicle Glycoprotein 2A Ligands in the Treatment of Epilepsy and Beyond
- (2016) Wolfgang Löscher et al. CNS DRUGS
- Brivaracetam: Rationale for discovery and preclinical profile of a selective SV2A ligand for epilepsy treatment
- (2016) Henrik Klitgaard et al. EPILEPSIA
- Brivaracetam, a selective high-affinity synaptic vesicle protein 2A (SV2A) ligand with preclinical evidence of high brain permeability and fast onset of action
- (2015) Jean-Marie Nicolas et al. EPILEPSIA
- An open-label, prospective, exploratory study of patients with epilepsy switching from levetiracetam to brivaracetam
- (2015) Stephen L. Yates et al. EPILEPSY & BEHAVIOR
- Brivaracetam Single and Multiple Rising Oral Dose Study in Healthy Japanese Participants: Influence of CYP2C19 Genotype
- (2014) Armel Stockis et al. Drug Metabolism and Pharmacokinetics
- Modulation of the conformational state of the SV2A protein by an allosteric mechanism as evidenced by ligand binding assays
- (2013) V Daniels et al. BRITISH JOURNAL OF PHARMACOLOGY
- Synaptic vesicle protein 2A: basic facts and role in synaptic function
- (2013) Julieta Griselda Mendoza-Torreblanca et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Progress report on new antiepileptic drugs: A summary of the Eleventh Eilat Conference (EILAT XI)
- (2012) Meir Bialer et al. EPILEPSY RESEARCH
- Binding characteristics of brivaracetam, a selective, high affinity SV2A ligand in rat, mouse and human brain: Relationship to anti-convulsant properties
- (2011) Michel Gillard et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Down-regulation Synaptic Vesicle Protein 2A in the Anterior Temporal Neocortex of Patients with Intractable Epilepsy
- (2009) Guibo Feng et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- The pharmacokinetics, CNS pharmacodynamics and adverse event profile of brivaracetam after multiple increasing oral doses in healthy men
- (2008) Paul Rolan et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A
- (2008) A Matagne et al. BRITISH JOURNAL OF PHARMACOLOGY
- A pilot trial of levetiracetam in eyelid myoclonia with absences (Jeavons syndrome)
- (2008) Pasquale Striano et al. EPILEPSIA
- Decreased expression of synaptic vesicle protein 2A, the binding site for levetiracetam, during epileptogenesis and chronic epilepsy
- (2008) Erwin A. van Vliet et al. EPILEPSIA
- Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures
- (2008) S. Noachtar et al. NEUROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now